Skip to Main Content

Paper Details

Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors.
0
2023
ER, ER+, ER+/HER2- invasive breast, Estrogen, Estrogen Receptor, HER2, Human, Tamoxifen, breast cancer, breast tumors, carcinoma, endocrine therapy, estrogen, estrogen receptor, estrogen receptor-positive (ER+)/HER2- breast cancer, human, malignant cell compartment, patients, primary cell suspensions, resistant subpopulations, single-cell RNA libraries, tamoxifen, tumor, tumors, women
Author NameAffiliation
Susana Garcia-RecioLineberger Comprehensive Cancer Center, University of North Carolina
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina
Charles M PerouUniversity of North Carolina at Chapel Hill
Charles M PerouUniversity of North Carolina
Charles M PerouUniversity of North Carolina
  • 1 - 5

Datasets

Release 1.2